Search Results - "He, Liuer"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Functions of N6-methyladenosine and its role in cancer by He, Liuer, Li, Huiyu, Wu, Anqi, Peng, Yulong, Shu, Guang, Yin, Gang

    Published in Molecular cancer (04-12-2019)
    “…N6-methyladenosine (m6A) is methylation that occurs in the N6-position of adenosine, which is the most prevalent internal modification on eukaryotic mRNA…”
    Get full text
    Journal Article
  2. 2

    Case report: MSI-H, EGFR mutation, and ground-glass nodules as diffuse pulmonary hematogenous metastases by He, Liuer, Li, Lin

    Published in Frontiers in immunology (28-10-2024)
    “…Ground-glass nodules (GGNs) are generally considered an early stage of lung cancer. The imaging characteristics and curative efficacy of multiple GGNs as…”
    Get full text
    Journal Article
  3. 3

    Characterization of Histone Deacetylase Mechanisms in Cancer Development by Hai, Rihan, He, Liuer, Shu, Guang, Yin, Gang

    Published in Frontiers in oncology (29-07-2021)
    “…Over decades of studies, accumulating evidence has suggested that epigenetic dysregulation is a hallmark of tumours. Post-translational modifications of…”
    Get full text
    Journal Article
  4. 4

    Efficient and Regioselective One-Pot Synthesis of 3-Substituted and 3,5-Disubstituted Isoxazoles by Tang, Shibing, He, Jinmei, Sun, Yongquan, He, Liuer, She, Xuegong

    Published in Organic letters (03-09-2009)
    “…A series of 3-substituted and 3,5-disubstituted isoxazoles have been efficiently synthesized in moderate to excellent yields by the reaction of…”
    Get full text
    Journal Article
  5. 5

    Efficient and Regioselective Synthesis of 5-Hydroxy-2-isoxazolines: Versatile Synthons for Isoxazoles, β-Lactams, and γ-Amino Alcohols by Tang, Shibing, He, Jinmei, Sun, Yongquan, He, Liuer, She, Xuegong

    Published in Journal of organic chemistry (19-03-2010)
    “…An efficient and highly regioselective protocol was developed for the preparation of 5-hydroxy-2-isoxazolines, which have been proved to be versatile synthons…”
    Get full text
    Journal Article
  6. 6

    Proteomic and metabolomic profiling of plasma predicts immune-related adverse events in older patients with advanced non-small cell lung cancer by Gao, Jiayi, Zhang, Ping, Nie, Xin, Tang, Min, Yuan, Yue, He, Liuer, Wang, Xue, Ma, Junling, Li, Lin

    Published in iScience (21-06-2024)
    “…The clinical success of immune checkpoint inhibitors is compromised by the fact of immune-related adverse events (irAEs), especially for older patients. To…”
    Get full text
    Journal Article
  7. 7

    Metastasis ability, genomic profile, subtype characteristic and curative efficacy of multiple pulmonary hematogenous metastases in lung cancer by He, Liuer, Nie, Xin, Gao, Jiayi, Yuan, Yue, Wang, Xue, Li, Xu, Guo, Fengzhu, Tang, Min, Zhang, Ping, Li, Lin

    Published in Clinical and translational medicine (01-03-2024)
    “…The CROWN study (N = 76) found that loratinib improved the intracranial objective response rate (iORR) (64.9% vs. 17.9%, p < 0.001) compared to clotozantinib…”
    Get full text
    Journal Article
  8. 8

    Concise Total Syntheses of (+)-Strictifolione and (6R)-6-[(4R,6R)-4,6-Dihydroxy-10-phenyldec-1-enyl]-5,6-dihydro-2H-pyran-2-one by Tang, Shibing, Xie, Xingang, Wang, Xiaolei, He, Liuer, Xu, Ke, She, Xuegong

    Published in Journal of organic chemistry (03-12-2010)
    “…Concise and efficient asymmetric total syntheses of (+)-strictifolione 1 and (6R)-6-[(4R,6R)-4,6-dihydroxy-10-phenyldec-1-enyl]-5,6-dihydro-2H-pyran-2-one 2…”
    Get full text
    Journal Article
  9. 9

    Ground-glass opacity showed response to immunotherapy in cancer patients by Wu, Fang, Hu, Chunhong, Liu, Xiaohan, Li, Yizheng, Zeng, Yue, He, Liuer, Liu, Junqi

    Published in Journal of clinical oncology (01-06-2022)
    “…e14605 Background: Ground glass opacities (GGO) are lesions with hazy density on CT. Immune checkpoint inhibitors (ICIs) achieved a significant improvement in…”
    Get full text
    Journal Article
  10. 10

    A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer by Fan, Lili, Lin, Ying, Lei, Han, Shu, Guang, He, Liuer, Yan, Zhipeng, Rihan, Hai, Yin, Gang

    Published in Aging (Albany, NY.) (20-09-2020)
    “…N6-methyladenosine (m 6 A) RNA methylation, involved in cancer initiation and progression, is dynamically regulated by the m 6 A RNA methylation regulators…”
    Get full text
    Journal Article
  11. 11

    A newly defined risk signature, consisting of three m 6 A RNA methylation regulators, predicts the prognosis of ovarian cancer by Fan, Lili, Lin, Ying, Lei, Han, Shu, Guang, He, Liuer, Yan, Zhipeng, Rihan, Hai, Yin, Gang

    Published in Aging (Albany, NY.) (20-09-2020)
    “…N6-methyladenosine (m A) RNA methylation, involved in cancer initiation and progression, is dynamically regulated by the m A RNA methylation regulators…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Facile total synthesis of the antimalarial nonenolide by Liu, Jian, Zhang, Ling, He, Jinmei, He, Liuer, Ma, Bowen, Pan, Xinfu, She, Xuegong

    Published in Tetrahedron: asymmetry (01-05-2008)
    “…The facile total synthesis of the antimalarial nonenolide 1 is reported. The convergent strategy features the use of reactions such as Sharpless asymmetric…”
    Get full text
    Journal Article